Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-15-014866
Filing Date
2015-02-17
Accepted
2015-02-17 19:52:57
Documents
2
Period of Report
2015-02-17

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 6711
2 EX-24 DOCUMENT attachment1.htm EX-24 4559
  Complete submission text file 0001209191-15-014866.txt   12706
Mailing Address 131 HARTWELL AVE 1ST FLOOR, SUITE 105 LEXINGTON MA 02421
Business Address 131 HARTWELL AVE 1ST FLOOR, SUITE 105 LEXINGTON MA 02421 781-676-2100
INOTEK PHARMACEUTICALS CORP (Issuer) CIK: 0001281895 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INOTEK PHARMACEUTICALS CORPORATION 131 HARTWELL AVENUE, SUITE 105 LEXINGTON MA 02421
Business Address
Baumgartner Rudolph (Reporting) CIK: 0001632878 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36829 | Film No.: 15625403